Xiaofei An
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Nephrology top 10%
Papers in
-
- Immune Response and Inflammation 2
-
- Chronic Kidney Disease and Diabetes 1
- Renal Diseases and Glomerulopathies 1
- Co-authors
- Jin‐an Zhang (4 shared papers)Qiuming Yao (4 shared papers)Chaodong Wu (3 shared papers)Yuqing Huo (3 shared papers)Honggui Li (2 shared papers)Xin Guo (2 shared papers)Md Nasrul Hoda (1 shared paper)Ruth B. Caldwell (1 shared paper)
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Gut Microbes (1 paper)Clinical Endocrinology (1 paper)Journal of Controlled Release (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaofei An
17 papers receiving 726 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 118
- Nephrology 48
- Endocrinology, Diabetes and Metabolism 99
- Molecular Biology 347
- Immunology 74
Countries citing papers authored by Xiaofei An
This map shows the geographic impact of Xiaofei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei An more than expected).
Fields of papers citing papers by Xiaofei An
This network shows the impact of papers produced by Xiaofei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei An. The network helps show where Xiaofei An may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 218 | |
| 2 | 2014 | 165 | |
| 3 | 2017 | 77 | |
| 4 | 2017 | 67 | |
| 5 | 2022 | 44 | |
| 6 | 2022 | 37 | |
| 7 | 2021 | 34 | |
| 8 | 2021 | 33 | |
| 9 | 2012 | 23 | |
| 10 | 2021 | 10 | |
| 11 | 2019 | 9 | |
| 12 | 2020 | 6 | |
| 13 | 2017 | 5 | |
| 14 | [Treatment of Early Diabetic Retinopathy by Liuwei Dihuang Pill Combined Ginkao Leaf Tablet]. | 2016 | 4 |
| 15 | 2022 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 1998 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2024 | 0 |
About Xiaofei An
Xiaofei An is a scholar working on Immunology, Nephrology, Cancer Research, Endocrinology, Diabetes and Metabolism and Transplantation, having authored 19 papers that have together received 738 indexed citations. Recurring topics across this work include Immune Response and Inflammation (2 papers), Hormonal and reproductive studies (2 papers), Nanoplatforms for cancer theranostics (1 paper), Biochemical Analysis and Sensing Techniques (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Renal Transplantation Outcomes and Treatments (1 paper), Birth, Development, and Health (1 paper) and Renal Diseases and Glomerulopathies (1 paper). The work is most often cited by research in Cancer Research (118 citations), Nephrology (48 citations), Endocrinology, Diabetes and Metabolism (99 citations), Molecular Biology (347 citations) and Immunology (74 citations). Xiaofei An has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jin‐an Zhang, Qiuming Yao, Chaodong Wu, Yuqing Huo, Honggui Li, Xin Guo, Md Nasrul Hoda, Ruth B. Caldwell, Yunchao Su and Xizhen Xu. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Gut Microbes, Clinical Endocrinology, Journal of Controlled Release and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.